JLHL279.00

Jupiter Life Line Hospitals Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSHCGMARKSANSMETROPOLISPARKHOSPSCORONAMcap ₹1,829 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,069.51,261.51,499.81,557.8
Other Income26.028.742.440.1
Total Income1,095.51,290.21,542.21,598.0
Expenses
+ Purchases of Stock-in-Trade191.8232.9299.1307.8
+ Changes in Inventories-2.3-2.8-11.9-11.2
+ Employee Benefit Expense189.9214.5256.3269.1
+ Finance Costs26.310.632.737.3
+ Depreciation & Amortisation42.457.087.692.9
+ Other Expenses451.9520.3612.9648.0
Total Expenses900.11,032.51,276.81,343.8
EBITDA238.2296.6343.3344.1
EBIT195.8239.6255.6251.2
Profit
PBT before Exceptional Items195.4257.7265.3254.1
+ Exceptional Items0.00.00.0-6.4
Pretax Income195.4257.7265.3247.7
+ Current Tax52.060.463.758.5
+ Deferred Tax-33.23.82.53.0
Tax Expense18.864.266.261.5
Net Income176.6193.5199.1186.2
+ Net Income — Continuing Ops176.6193.5199.1186.2
+ Other Comprehensive Income1.2-1.2-4.51.9
Total Comprehensive Income177.9192.3194.6188.2
Net Income to Common0.0193.2194.4188.0
Minority Interest0.00.30.20.1
Per Share
Basic EPS28.6529.4729.5928.62
Diluted EPS28.6529.4729.5928.62
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs0.0-4.70.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.2-4.51.9
+ Items NOT to be Reclassified to P&L1.2-1.6
+ Tax on Items NOT to be Reclassified-0.44.5-1.9
Comprehensive Income — Owners of Parent0.00.0194.4150.5
Comprehensive Income — Non-controlling Interests0.00.00.20.1
Per Share — as-filed variants
Basic EPS — Continuing Operations28.6529.4729.5928.62
Diluted EPS — Continuing Operations28.6529.4729.5928.62
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit880.01,031.41,212.51,261.2
Gross Margin %82.2881.7680.8580.96
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)195.4257.7265.3254.1
− Exceptional Items (reconciliation)0.00.00.0-6.4
Net Income Adj (tax-effected)176.6193.5199.1191.1
EPS Adj28.6529.4729.5929.36
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital65.665.665.665.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.